EP3411478
OPTIMIZED FACTOR VIII GENES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.1.2017EP published:
8.6.2022EP application number:
17705236.2
EPO information:
European Patent Register
Max expiry date:
30.1.2037
Title in English:
OPTIMIZED FACTOR VIII GENESLanguage of the patent:
English
Timeline
Today
31.1.2017EP application
8.6.2022EP Publication
Owner
Name:
Bioverativ Therapeutics Inc.Address:
225 Second Avenue, Waltham, MA 02451, US
Inventor
Name:
TAN, SiyuanAddress:
Lexington, Massachusetts 02421, US
Name:
LIU, TongyaoAddress:
Lexington, Massachusetts 02421, US
Priority
Number:
201662289696 PDate:
1.2.2016Country:
US
Number:
201662409739 PDate:
18.10.2016Country:
US
Classification
Categories:
C12N 9/64